The new vaccine protects against omicron subvariants and the original coronavirus.
The hints Ebos dropped about its second half were mostly positive.
The company’s net profit for the six months ended December rose to $132.2m.
Ebos said its LifeHealthcare business, bought for A$1.28 billion in May last year, performed to expectations.